4.5 Review

Diagnosis, pathogenesis and treatment of myositis: recent advances

期刊

CLINICAL AND EXPERIMENTAL IMMUNOLOGY
卷 175, 期 3, 页码 349-358

出版社

WILEY
DOI: 10.1111/cei.12194

关键词

muscle immunology; disease; myositis; neuroimmunology

资金

  1. Bayer
  2. Biotest
  3. CSL Behring
  4. Novartis
  5. Octapharma

向作者/读者索取更多资源

Dermatomyositis (DM), polymyositis (PM), necrotizing myopathy (NM) and inclusion body myositis (IBM) are four distinct subtypes of idiopathic inflammatory myopathies - in short myositis. Recent studies have shed some light on the unique pathogenesis of each entity. Some of the clinical features are distinct, but muscle biopsy is indispensable for making a reliable diagnosis. The use of magnetic resonance imaging of skeletal muscles and detection of myositis-specific autoantibodies have become useful additions to our diagnostic repertoire. Only few controlled trials are available to substantiate current treatment approaches for myositis and hopes are high that novel modalities will become available within the next few years. In this review we provide an up-to-date overview of the pathogenesis and diagnostic approach of myositis. We aim to present a guide towards therapeutic and general management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据